Concert posts 3Q profit

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported third-quarter net income of $128.1 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Lexington, Massachusetts-based company said it had net income of $5.44. Losses, adjusted for non-recurring gains, came to 70 cents per share.

The biopharmaceutical company posted revenue of $143.8 million in the period. Its adjusted revenue was $17,000.

Concert shares have risen 60 percent since the beginning of the year. The stock has more than doubled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE